Antibiotiki i Khimioterapiya
Published by Publishing House OKI
ISSN : 0235-2990
Abbreviation : Antibiot. Khimioterapiya
Aims & Scope
The aim of the journal: The main theme of the journal is focused on informing doctors, pharmacologists, biologists, chemists, healthcare providers, clinicians, pharmaceutical companies, and other professionals about new antibacterial, antifungal, antiviral, antitumor, immunocorrector, and non-steroidal anti-inflammatory drugs; about the mechanisms of antibiotic resistance of infectious agents, the effectiveness and tolerability of antibacterial drugs in experiments and in clinic; about modern express methods for identifying and determining the sensitivity of infectious pathogens; about principles of rational antibiotic therapy and antibiotic prophylaxis of the most common infectious and inflammatory diseases.
View Aims & ScopeMetrics & Ranking
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.136 |
Quartile
Year | Value |
---|---|
2024 | Q4 |
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Practical Experience of Using Riamilovir in Treatment of Patients with Moderate COVID-19
Citation: 18
Authors: A. U., V. V., A. S., E. V., E. P., E. P., T. Yu., Yu. S., P. V.
-
Infections Caused by Carbapenem-Resistant Enterobacterales: Epidemiology, Clinical Significance, and Possibilities for Antibiotic Therapy Optimization
Citation: 15
Authors: S. V., M. P., A. O.
-
Clinical Efficiency and Safety of Riamilovir for Treating Patients with SARS-CoV-2 Infection
Citation: 12
Authors: K. V., O. V., K. V., I. I., N. I., V. S., K. V., P. V., A. K.
-
Meta-analysis of randomized controlled clinical trials of Riamilovir efficacy in the etiotropic therapy of acute respiratory viral infection
Citation: 11
Authors: A. U., O. P., N. A., O. V., K. V., E. V., E. P., Yu. S., P. V., S. V., A. V.
-
Associated resistance of Escherichia coli isolated from humans and animals to polymyxin and beta-lactam antibiotics
Citation: 11
Authors: O. S., V. A., A. A., I. V., S. R., S. A., O. A., K. G., T. M., D. A., O. E., S. V.
-
The Efficacy and Safety of Riamilovir in the Treatment of Patients with COVID-19
Citation: 10
Authors: Ð. U., Ð . V., S. U.
-
Appointment of Antimicrobial Medications in a Hospital Depending on the Results of Microbiological Monitoring of HAI
Citation: 8
Authors: S. D., O. E., I. V., A. S.
-
Antibacterial Activity of the Halogen- and Nitro Derivatives of Benzimidazole Against <i>Bacillus Subtilis</i>
Citation: 7
Authors: R. S., D. O., A. V., L. I., A. A.